Premium
Human Embryonic Stem Cell Research in the United States: Some Policy Options for Industry Development
Author(s) -
HARVEY OLIVIA
Publication year - 2009
Publication title -
politics and policy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.259
H-Index - 23
eISSN - 1747-1346
pISSN - 1555-5623
DOI - 10.1111/j.1747-1346.2008.00161.x
Subject(s) - dominance (genetics) , embryonic stem cell , government (linguistics) , argument (complex analysis) , politics , political science , business , biology , law , philosophy , biochemistry , linguistics , gene
Since 1998, a significant global industry has developed around human embryonic stem cell (hESC) science, in which U.S.‐based research is highly prominent. Yet the continued success of the United States in the global economy of hESC is not expected to last in the long term. In America, hESC research is both highly contentious and morally imperative; public interest is high, yet as a whole, the sector is seen to be underperforming. The regulatory, political, economic, and scientific limitations surrounding the development of hESC research in the United States have been widely discussed. The argument in this article is that the dominance of the biotechnology innovation model exacerbates the existing limitations to the long‐term success of hESC research in the United States, and that the federal government has a more proactive role to play in managing stem cell innovation if U.S. advantage is going to be maintained.